Literature DB >> 17269671

Using statistical analysis for setting process validation acceptance criteria for biotech products.

Xiangyang Wang1, Abe Germansderfer, Jean Harms, Anurag S Rathore.   

Abstract

This paper discusses the challenges of setting process validation acceptance criteria for biotech products for cases where using statistical tools is appropriate. Data are analyzed under three different scenarios that are frequently encountered in biotech applications. Scenario A represents the case when a small data set around center point conditions is available for setting acceptance criteria. Scenario B represents the case when a larger data set within normal operation conditions is available for setting acceptance criteria. Scenario C represents the case when a large characterization data set is available for setting acceptance criteria and it is possible to accurately model the impact of operation conditions on performance of the step. Statistical approaches including mean +/- 3SD, tolerance interval analysis, prediction profiler, and Monte Carlo simulation are applied to the different scenarios. Strengths and shortcomings of the different statistical tools are discussed, and the best approach for each scenario is recommended. It is shown that selection of the right statistical approach is a critical first step toward setting appropriate acceptance criteria.

Mesh:

Year:  2007        PMID: 17269671     DOI: 10.1021/bp060359c

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  5 in total

1.  Ellagic acid production by Aspergillus niger in solid state fermentation of pomegranate residues.

Authors:  Armando Robledo; Antonio Aguilera-Carbó; Raúl Rodriguez; José Luis Martinez; Yolanda Garza; Cristobal N Aguilar
Journal:  J Ind Microbiol Biotechnol       Date:  2008-01-29       Impact factor: 3.346

2.  Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product.

Authors:  Kyoung Hoon Lee; Jihun Lee; Jin Soo Bae; Yeon Jung Kim; Hyun Ah Kang; Sung Hwan Kim; So Jung Lee; Ki Jung Lim; Jung Woo Lee; Soon Kwan Jung; Shin Jae Chang
Journal:  MAbs       Date:  2018-03-06       Impact factor: 5.857

3.  Specification-driven acceptance criteria for validation of biopharmaceutical processes.

Authors:  Lukas Marschall; Christopher Taylor; Thomas Zahel; Marco Kunzelmann; Alexander Wiedenmann; Beate Presser; Joey Studts; Christoph Herwig
Journal:  Front Bioeng Biotechnol       Date:  2022-09-23

4.  Development and validation of an automated and marker-free CT-based spatial analysis method (CTSA) for assessment of femoral hip implant migration: In vitro accuracy and precision comparable to that of radiostereometric analysis (RSA).

Authors:  Thierry Scheerlinck; Mathias Polfliet; Rudi Deklerck; Gert Van Gompel; Nico Buls; Jef Vandemeulebroucke
Journal:  Acta Orthop       Date:  2015-12-03       Impact factor: 3.717

5.  Process Characterization by Definitive Screening Design Approach on DNA Vaccine Production.

Authors:  Lalintip Hocharoen; Sarawuth Noppiboon; Panit Kitsubun
Journal:  Front Bioeng Biotechnol       Date:  2020-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.